Concepedia

Vasily Shuvaev

VS

13

Publications

330

Citations

12

H-Index

2015

Active since

Affiliations

Russian Research Institute of Hematology and Transfusiology(Current)

National Medical Research Center for Hematology

Federal Almazov North-West Medical Research Centre

Botkin Hospital

City Clinical Hospital

Vasily Shuvaev is an author at Russian Research Institute of Hematology and Transfusiology specializing in medicine, hematology, and cancer research.

ORCID

Top concepts

Publications per year

2015–2024

13

Publications

13

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

François-Xavier Mahon, Carla Boquimpani, Dong‐Wook Kim et al. · Annals of Internal Medicine · 2018 · 127 citations · Full text

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

A. L. Melikyan, Irina N. Subortseva, Vasily Shuvaev et al. · Clinical oncohematology · 2021 · 25 citations · Full text

, , +13

Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia

Anna Turkina, A.Yu. Zaritskii, Vasily Shuvaev et al. · Clinical oncohematology · 2017 · 22 citations · Full text

Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop

Timothy P. Hughes, Carla Boquimpani, Naoto Takahashi et al. · Blood · 2016 · 21 citations

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Elias Jabbour, Vivian G. Oehler, Paul Koller et al. · JAMA Oncology · 2024 · 21 citations · Full text

Rows per page

1–5 of 13